Work

Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program

Year: 2021

Type: editorial

Source: Pharmacogenomics

DOI: 10.2217/pgs-2020-0173

Authors: Olivia M Dong, Jill Bates, Catherine Chanfreau-Coffinier, Michael Naglich, Michael J Kelley, Laurence J Meyer, Michael Icardi, Jason L Vassy, Peruvemba Sriram, Craig William Heise, Salvador Rivas, Maria Ribeiro, Russell Jacobitz, Susan Rozelle, Jennifer G Chapman, Deepak Voora

Institutions: Duke University, Durham VA Health Care System, Duke Medical Center, University of North Carolina at Chapel Hill, VA Salt Lake City Healthcare System, Durham VA Medical Center, Institute for Medical Research, United States Department of Veterans Affairs, University of Utah, Veterans Health Administration, Harvard University, VA Boston Healthcare System, North Florida/South Georgia Veterans Health System, Phoenix VA Health Care System, University of Arizona College of Medicine- Phoenix, Emory University, Atlanta VA Medical Center

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Sanford Health, National Human Genome Research Institute

Award: Postdoctoral training in genomic medicine research

OpenAlex ID: W3120116794

Cites: 11

Cited by: 34

Related to: 10